GlaxoSmithKline says lung drug meets late-stage study goals - Reuters

Reuters

GlaxoSmithKline says lung drug meets late-stage study goals Reuters Drugmaker GlaxoSmithKline Plc said its experimental combination therapy for a chronic lung problem met the main goal of a late-stage study, allowing the company to apply for marketing of the drug by the end of 2016. The company said the study met its ... and more »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGH86ObsCO46Yo8f1uB8yKwrANb_w&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779136007101&ei=BrJnV-jiNYLf3AGkgK6QCg&url=http://in.reuters.com/article/us-gsk-study-idINKCN0Z60M2
via IFTTT